RetinAI Discovery vs Altris AI Detailed comparison features, price

RetinAI Discovery

RetinAI Discovery stands at the forefront of healthcare innovation, offering a comprehensive data management and analysis platform specifically designed for ophthalmology. The platform seamlessly integrates multiple data formats, from DICOM-compliant imaging to proprietary formats, while providing advanced AI-powered analysis capabilities for disease progression and treatment outcomes.

The platform features CE-marked AI models for OCT analysis, layer and fluid segmentation, and supports various ophthalmological conditions including AMD, DR, DME, CME, and GA. With its cloud-based infrastructure, the system enables secure global collaboration, real-time data monitoring, and automated biomarker analysis, serving both clinical practice and research environments.

Altris AI

Altris AI provides an advanced ophthalmic image management system enhanced by Artificial Intelligence, designed specifically for ophthalmologists and optometrists. This platform automatically analyzes Optical Coherence Tomography (OCT) scans to identify pathological conditions, significantly improving diagnostic workflows. It is compatible with all OCT devices and focuses on aiding eye care specialists in making more confident and accurate diagnostic decisions, reducing potential errors and the risk of burnout.

The system facilitates early detection of over 70 retina pathologies and biomarkers, including early glaucoma risk assessment and quantitative analysis for monitoring disease progression. Altris AI enhances patient care by enabling more detailed screenings, leading to earlier detection and more effective treatment strategies. It also serves as an educational tool for patients, helping them understand their condition and treatment plan, thereby increasing compliance and loyalty. The platform adheres to strict compliance standards, including FDA clearance, CE certification, GDPR, and HIPAA.

Search AI Tools

Overview